When the first antiepileptic drug fails in a patient with juvenile myoclonic epilepsy
Juvenile myoclonic epilepsy is one of the most common types of epilepsy seen in an adult epilepsy clinic. Most patients have a good prognosis, particularly when treated with valproate, but a significant minority are more difficult to treat. In this article, we will focus on a management strategy whe...
Gespeichert in:
| Veröffentlicht in: | Practical Neurology 2010-08, Vol.10 (4), p.208-218 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 218 |
|---|---|
| container_issue | 4 |
| container_start_page | 208 |
| container_title | Practical Neurology |
| container_volume | 10 |
| creator | Nicolson, Andrew Marson, Anthony G |
| description | Juvenile myoclonic epilepsy is one of the most common types of epilepsy seen in an adult epilepsy clinic. Most patients have a good prognosis, particularly when treated with valproate, but a significant minority are more difficult to treat. In this article, we will focus on a management strategy when the initial antiepileptic drug is unsuccessful and outline an approach that translates directly to the clinic. |
| doi_str_mv | 10.1136/jnnp.2010.217976 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_734000824</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>734000824</sourcerecordid><originalsourceid>FETCH-LOGICAL-b345t-2ec189cd267a336c65fe155ae8d3ecf8089f4f85093515d0d78b5a9c1e10e7d43</originalsourceid><addsrcrecordid>eNqF0M-L1DAUB_Agirs7evckAZE9SNf8TnpcBnWFcfXgqreQSRMntU1r0qrz35uh4whePOWF93mPxxeAJxhdYUzFyzbG8Yqg8iVY1lLcA-eYSVZJKcT9U83VGbjIuUWoIFo_BGcECSY5kefg7vPORTjtHPQh5QmaOAU3hs6NU7CwSfNX6E3oMgwRGjia0o0T_BmmHWznHy4WCfv9YLshFr9M5v0j8MCbLrvHx3cF7l6_-ri-qTbv37xdX2-qLWV8qoizWNW2IUIaSoUV3DvMuXGqoc56hVTtmVcc1ZRj3qBGqi03tcUOIycbRlfgctk7puH77PKk-5Ct6zoT3TBnLSlDCClykM_-ke0wp1iO01gqLLhSRBaFFmXTkHNyXo8p9CbtNUb6kLg-JK4Piesl8TLy9Lh43vauOQ38ibiA50dgsjWdTybakP86ihRjZfcKVIsLeXK_Tn2TvmkhqeT69tNaq80t-fLhXa1vin-x-G3f_v_M34FnpgQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1781658827</pqid></control><display><type>article</type><title>When the first antiepileptic drug fails in a patient with juvenile myoclonic epilepsy</title><source>MEDLINE</source><source>BMJ Journals - NESLi2</source><creator>Nicolson, Andrew ; Marson, Anthony G</creator><creatorcontrib>Nicolson, Andrew ; Marson, Anthony G</creatorcontrib><description>Juvenile myoclonic epilepsy is one of the most common types of epilepsy seen in an adult epilepsy clinic. Most patients have a good prognosis, particularly when treated with valproate, but a significant minority are more difficult to treat. In this article, we will focus on a management strategy when the initial antiepileptic drug is unsuccessful and outline an approach that translates directly to the clinic.</description><identifier>ISSN: 1474-7758</identifier><identifier>EISSN: 1474-7766</identifier><identifier>DOI: 10.1136/jnnp.2010.217976</identifier><identifier>PMID: 20647527</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd</publisher><subject>Adolescent ; Anticonvulsants - adverse effects ; Anticonvulsants - therapeutic use ; Biological and medical sciences ; Child ; Clinical Protocols ; Disease Management ; Drug Resistance - physiology ; Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy ; Humans ; Medical sciences ; Myoclonic Epilepsy, Juvenile - drug therapy ; Nervous system (semeiology, syndromes) ; Neurology ; Treatment Failure</subject><ispartof>Practical Neurology, 2010-08, Vol.10 (4), p.208-218</ispartof><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>2015 INIST-CNRS</rights><rights>Copyright: 2010 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b345t-2ec189cd267a336c65fe155ae8d3ecf8089f4f85093515d0d78b5a9c1e10e7d43</citedby><cites>FETCH-LOGICAL-b345t-2ec189cd267a336c65fe155ae8d3ecf8089f4f85093515d0d78b5a9c1e10e7d43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pn.bmj.com/content/10/4/208.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttps://pn.bmj.com/content/10/4/208.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,315,781,785,793,3197,23575,27926,27928,27929,77604,77635</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23084411$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20647527$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nicolson, Andrew</creatorcontrib><creatorcontrib>Marson, Anthony G</creatorcontrib><title>When the first antiepileptic drug fails in a patient with juvenile myoclonic epilepsy</title><title>Practical Neurology</title><addtitle>Pract Neurol</addtitle><description>Juvenile myoclonic epilepsy is one of the most common types of epilepsy seen in an adult epilepsy clinic. Most patients have a good prognosis, particularly when treated with valproate, but a significant minority are more difficult to treat. In this article, we will focus on a management strategy when the initial antiepileptic drug is unsuccessful and outline an approach that translates directly to the clinic.</description><subject>Adolescent</subject><subject>Anticonvulsants - adverse effects</subject><subject>Anticonvulsants - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Clinical Protocols</subject><subject>Disease Management</subject><subject>Drug Resistance - physiology</subject><subject>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Myoclonic Epilepsy, Juvenile - drug therapy</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurology</subject><subject>Treatment Failure</subject><issn>1474-7758</issn><issn>1474-7766</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqF0M-L1DAUB_Agirs7evckAZE9SNf8TnpcBnWFcfXgqreQSRMntU1r0qrz35uh4whePOWF93mPxxeAJxhdYUzFyzbG8Yqg8iVY1lLcA-eYSVZJKcT9U83VGbjIuUWoIFo_BGcECSY5kefg7vPORTjtHPQh5QmaOAU3hs6NU7CwSfNX6E3oMgwRGjia0o0T_BmmHWznHy4WCfv9YLshFr9M5v0j8MCbLrvHx3cF7l6_-ri-qTbv37xdX2-qLWV8qoizWNW2IUIaSoUV3DvMuXGqoc56hVTtmVcc1ZRj3qBGqi03tcUOIycbRlfgctk7puH77PKk-5Ct6zoT3TBnLSlDCClykM_-ke0wp1iO01gqLLhSRBaFFmXTkHNyXo8p9CbtNUb6kLg-JK4Piesl8TLy9Lh43vauOQ38ibiA50dgsjWdTybakP86ihRjZfcKVIsLeXK_Tn2TvmkhqeT69tNaq80t-fLhXa1vin-x-G3f_v_M34FnpgQ</recordid><startdate>201008</startdate><enddate>201008</enddate><creator>Nicolson, Andrew</creator><creator>Marson, Anthony G</creator><general>BMJ Publishing Group Ltd</general><general>BMJ Publishing Group</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>201008</creationdate><title>When the first antiepileptic drug fails in a patient with juvenile myoclonic epilepsy</title><author>Nicolson, Andrew ; Marson, Anthony G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b345t-2ec189cd267a336c65fe155ae8d3ecf8089f4f85093515d0d78b5a9c1e10e7d43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adolescent</topic><topic>Anticonvulsants - adverse effects</topic><topic>Anticonvulsants - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Clinical Protocols</topic><topic>Disease Management</topic><topic>Drug Resistance - physiology</topic><topic>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Myoclonic Epilepsy, Juvenile - drug therapy</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurology</topic><topic>Treatment Failure</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nicolson, Andrew</creatorcontrib><creatorcontrib>Marson, Anthony G</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Practical Neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nicolson, Andrew</au><au>Marson, Anthony G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>When the first antiepileptic drug fails in a patient with juvenile myoclonic epilepsy</atitle><jtitle>Practical Neurology</jtitle><addtitle>Pract Neurol</addtitle><date>2010-08</date><risdate>2010</risdate><volume>10</volume><issue>4</issue><spage>208</spage><epage>218</epage><pages>208-218</pages><issn>1474-7758</issn><eissn>1474-7766</eissn><abstract>Juvenile myoclonic epilepsy is one of the most common types of epilepsy seen in an adult epilepsy clinic. Most patients have a good prognosis, particularly when treated with valproate, but a significant minority are more difficult to treat. In this article, we will focus on a management strategy when the initial antiepileptic drug is unsuccessful and outline an approach that translates directly to the clinic.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd</pub><pmid>20647527</pmid><doi>10.1136/jnnp.2010.217976</doi><tpages>11</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1474-7758 |
| ispartof | Practical Neurology, 2010-08, Vol.10 (4), p.208-218 |
| issn | 1474-7758 1474-7766 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_734000824 |
| source | MEDLINE; BMJ Journals - NESLi2 |
| subjects | Adolescent Anticonvulsants - adverse effects Anticonvulsants - therapeutic use Biological and medical sciences Child Clinical Protocols Disease Management Drug Resistance - physiology Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy Humans Medical sciences Myoclonic Epilepsy, Juvenile - drug therapy Nervous system (semeiology, syndromes) Neurology Treatment Failure |
| title | When the first antiepileptic drug fails in a patient with juvenile myoclonic epilepsy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T08%3A01%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=When%20the%20first%20antiepileptic%20drug%20fails%20in%20a%20patient%20with%20juvenile%20myoclonic%20epilepsy&rft.jtitle=Practical%20Neurology&rft.au=Nicolson,%20Andrew&rft.date=2010-08&rft.volume=10&rft.issue=4&rft.spage=208&rft.epage=218&rft.pages=208-218&rft.issn=1474-7758&rft.eissn=1474-7766&rft_id=info:doi/10.1136/jnnp.2010.217976&rft_dat=%3Cproquest_cross%3E734000824%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1781658827&rft_id=info:pmid/20647527&rfr_iscdi=true |